• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛛网膜下腔出血后严重症状性血管痉挛时持续局部动脉内尼莫地平给药。

Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.

机构信息

Department of Neurosurgery, Klinikum Stuttgart, Germany.

出版信息

Neurosurgery. 2011 Jun;68(6):1541-7; discussion 1547. doi: 10.1227/NEU.0b013e31820edd46.

DOI:10.1227/NEU.0b013e31820edd46
PMID:21311378
Abstract

BACKGROUND

Cerebral vasospasm (CV) is a potentially disastrous consequence of subarachnoid hemorrhage despite medical treatment. Nimodipine is a potent drug for vessel relaxation, but side effects may preclude a sufficient dose.

OBJECTIVE

To explore whether continuous local intra-arterial nimodipine administration (CLINA) can reverse vasospasm and prevent delayed ischemic neurological deficit.

METHODS

Six consecutive subarachnoid hemorrhage patients (5 women; mean age, 47.2 years) with severe CV despite maximum medical therapy underwent CLINA within 2 hours after the onset of clinical symptoms. After anticoagulation, microcatheters were inserted distally in the concerning supra-aortic vessels. Glyceryl trinitrate injection (2 mg) was followed by CLINA (nimodipine 0.4 mg/h for 70-147 hours). Duration of CLINA was determined by neurological status, transcranial Doppler sonography, and partial tissue oxygen pressure values.

RESULTS

In all patients, neurological deficits improved or partial tissue oxygen pressure values returned to normal and transcranial Doppler sonography confirmed a reduced blood flow velocity within 12 hours. Magnetic resonance imaging showed no ischemic lesion caused by CV. Neurological outcome was good (modified Rankin Scale score, 0-2) in 3 patients, whereas 1 patient had a moderate clinical outcome (modified Rankin Scale score, 3-4) and 2 patients had a poor outcome (modified Rankin Scale score, 5) because of the SAH.

CONCLUSION

Preliminary data show that CLINA is a straightforward, effective, and safe option for patients with severe CV refractory to medical therapy. Dilation of spastic arteries starts within a few hours and is lasting. Indication for CLINA is peripheral and diffuse CV at any location.

摘要

背景

尽管进行了医学治疗,脑血管痉挛(CV)仍是蛛网膜下腔出血的一种潜在灾难性后果。尼莫地平是一种有效的血管松弛药物,但副作用可能会排除足够的剂量。

目的

探讨持续局部动脉内尼莫地平给药(CLINA)是否能逆转血管痉挛并预防迟发性缺血性神经功能缺损。

方法

6 例连续的蛛网膜下腔出血患者(5 例女性;平均年龄 47.2 岁),尽管接受了最大的药物治疗,但仍出现严重的 CV,在出现临床症状后 2 小时内接受 CLINA。抗凝后,微导管远端插入相关的主动脉上血管。注射硝化甘油(2mg)后,给予 CLINA(尼莫地平 0.4mg/h,持续 70-147 小时)。CLINA 的持续时间由神经状态、经颅多普勒超声和部分组织氧分压值决定。

结果

所有患者的神经功能缺损均改善或部分组织氧分压值恢复正常,经颅多普勒超声证实血流速度在 12 小时内降低。磁共振成像显示无 CV 引起的缺血性病变。3 例患者的神经功能预后良好(改良 Rankin 量表评分 0-2),1 例患者的临床预后中度(改良 Rankin 量表评分 3-4),2 例患者的预后不良(改良 Rankin 量表评分 5),因为有蛛网膜下腔出血。

结论

初步数据表明,CLINA 是一种简单、有效、安全的治疗方法,适用于对药物治疗无效的严重 CV 患者。痉挛动脉的扩张在数小时内开始并持续。CLINA 的适应证是任何部位的外周性和弥漫性 CV。

相似文献

1
Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.蛛网膜下腔出血后严重症状性血管痉挛时持续局部动脉内尼莫地平给药。
Neurosurgery. 2011 Jun;68(6):1541-7; discussion 1547. doi: 10.1227/NEU.0b013e31820edd46.
2
Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.高剂量动脉内米力农及动脉内米力农与尼莫地平联合输注作为难治性脑血管痉挛的抢救治疗方法
Interv Neuroradiol. 2017 Dec;23(6):636-643. doi: 10.1177/1591019917732288. Epub 2017 Sep 28.
3
Intraarterial nimodipine for the treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a preliminary study.经动脉尼莫地平治疗动脉瘤性蛛网膜下腔出血后症状性血管痉挛:初步研究。
Neurol India. 2011 Nov-Dec;59(6):810-6. doi: 10.4103/0028-3886.91356.
4
Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage.动脉内注射罂粟碱或尼莫地平对蛛网膜下腔出血后脑血管痉挛患者血管直径的影响。
Br J Neurosurg. 2012 Aug;26(4):517-24. doi: 10.3109/02688697.2011.650737. Epub 2012 Feb 3.
5
Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.鞘内注射尼莫地平治疗对药物及血管内治疗无效的出血后脑血管痉挛的可行性与安全性
Clin Neurol Neurosurg. 2008 Sep;110(8):784-90. doi: 10.1016/j.clineuro.2008.05.001. Epub 2008 Jun 12.
6
Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion.持续动脉内输注尼莫地平治疗蛛网膜下腔出血中的难治性血管痉挛。
Acta Neurochir Suppl. 2011;112:93-6. doi: 10.1007/978-3-7091-0661-7_16.
7
Long-Term, Continuous Intra-Arterial Nimodipine Treatment of Severe Vasospasm After Aneurysmal Subarachnoid Hemorrhage.动脉瘤性蛛网膜下腔出血后严重血管痉挛的长期持续动脉内尼莫地平治疗
World Neurosurg. 2016 Apr;88:104-112. doi: 10.1016/j.wneu.2015.11.081. Epub 2015 Dec 28.
8
Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.蛛网膜下腔出血后动脉内和静脉内尼莫地平治疗脑血管痉挛对脑血管反应性和氧合的影响
World Neurosurg. 2017 May;101:372-378. doi: 10.1016/j.wneu.2017.02.014. Epub 2017 Feb 14.
9
Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.动脉瘤性蛛网膜下腔出血后严重难治性脑血管痉挛患者持续动脉内输注尼莫地平:一项可行性研究及结果
Acta Neurochir (Wien). 2015 Dec;157(12):2041-50. doi: 10.1007/s00701-015-2597-z. Epub 2015 Oct 6.
10
Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.难治性脑血管痉挛患者连续介入动脉内治疗后的临床病程及监测参数
World Neurosurg. 2017 Apr;100:504-513. doi: 10.1016/j.wneu.2016.12.110. Epub 2017 Jan 26.

引用本文的文献

1
Continuous Intra-arterial Infusion of Verapamil for Severe Vasospasm Treatment After Subarachnoid Hemorrhage: A Case Report.蛛网膜下腔出血后持续动脉内输注维拉帕米治疗严重血管痉挛:一例报告
Cureus. 2025 Apr 19;17(4):e82561. doi: 10.7759/cureus.82561. eCollection 2025 Apr.
2
Combined stent retriever angioplasty and continuous intra-arterial nimodipine infusion as salvage therapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage: illustrative case.联合使用支架取栓血管成形术和动脉内持续输注尼莫地平作为蛛网膜下腔出血后脑血管痉挛和迟发性脑缺血的挽救治疗:病例说明
J Neurosurg Case Lessons. 2023 Oct 2;6(14). doi: 10.3171/CASE23339.
3
Treatment of Cerebral Vasospasm With Continuous Intra-Arterial Nimodipine: A Case Report.
持续动脉内输注尼莫地平治疗脑血管痉挛:一例报告
Cureus. 2022 Oct 20;14(10):e30507. doi: 10.7759/cureus.30507. eCollection 2022 Oct.
4
The Local Intraarterial Administration of Nimodipine Might Positively Affect Clinical Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage and Delayed Cerebral Ischemia.尼莫地平局部动脉内给药可能对动脉瘤性蛛网膜下腔出血和迟发性脑缺血患者的临床结局产生积极影响。
J Clin Med. 2022 Apr 5;11(7):2036. doi: 10.3390/jcm11072036.
5
Continuous Intraarterial Nimodipine Infusion for the Treatment of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Retrospective, Single-Center Cohort Trial.持续动脉内输注尼莫地平治疗动脉瘤性蛛网膜下腔出血后迟发性脑缺血:一项回顾性单中心队列试验
Front Neurol. 2022 Mar 15;13:829938. doi: 10.3389/fneur.2022.829938. eCollection 2022.
6
Adverse Events and Complications in Continuous Intra-arterial Nimodipine Infusion Therapy After Aneurysmal Subarachnoid Hemorrhage.动脉瘤性蛛网膜下腔出血后持续动脉内输注尼莫地平治疗的不良事件和并发症
Front Neurol. 2022 Feb 18;12:812898. doi: 10.3389/fneur.2021.812898. eCollection 2021.
7
Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid haemorrhage - neurological and radiological outcome.颅内尼莫地平治疗动脉瘤性蛛网膜下腔出血后严重脑血管痉挛 - 神经学和影像学结果。
Neuroradiol J. 2022 Apr;35(2):213-219. doi: 10.1177/19714009211036695. Epub 2021 Aug 5.
8
Efficacy and safety of cilostazol-nimodipine combined therapy on delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a prospective, randomised, double-blinded, placebo-controlled trial protocol.西洛他唑-尼莫地平联合治疗对动脉瘤性蛛网膜下腔出血后迟发性脑缺血的疗效和安全性:一项前瞻性、随机、双盲、安慰剂对照试验方案
BMJ Open. 2020 Oct 5;10(10):e036217. doi: 10.1136/bmjopen-2019-036217.
9
Endovascular Rescue Treatment for Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Is Safe and Effective.蛛网膜下腔出血后迟发性脑缺血的血管内抢救治疗安全有效。
Front Neurol. 2019 Feb 21;10:136. doi: 10.3389/fneur.2019.00136. eCollection 2019.
10
Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage.口服或持续经动脉尼莫地平治疗颅内动脉瘤或中脑周围蛛网膜下腔出血后患者的动脉低血压发生率。
Neurocrit Care. 2019 Aug;31(1):32-39. doi: 10.1007/s12028-019-00676-w.